Propylamine → HCID 54340136, compound
Reaction equation
Cl[CH2:2][C:3]1[O:7][N:6]=[C:5]([C:8]2[N:9]=[CH:10][N:11]3[C:17]4[CH:18]=[CH:19][CH:20]=[CH:21][C:16]=4[C:15](=[O:22])[N:14]4[CH2:23][CH2:24][CH2:25][C@H:13]4[C:12]=23)[N:4]=1.[CH2:26]([NH2:29])[CH2:27][CH3:28]>CN(C)C=O>[CH2:26]([NH:29][CH2:2][C:3]1[O:7][N:6]=[C:5]([C:8]2[N:9]=[CH:10][N:11]3[C:17]4[CH:18]=[CH:19][CH:20]=[CH:21][C:16]=4[C:15](=[O:22])[N:14]4[CH2:23][CH2:24][CH2:25][C@H:13]4[C:12]=23)[N:4]=1)[CH2:27][CH3:28]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of 710 mg (2.0 mmol) of (S)-1-(5-chloromethyl-1,2,4-oxadiazol-3-yl)-11,12,13,13a-tetrahydro-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepin-9-one in 10 ml of N,N-dimethylformamide was treated with 0.5 ml (6.0 mmol) of propylamine and stirred at room temperature under argon for 2 hrs. The solution was evaporated, the residue was triturated in 5 ml of water and the crystals were filtered off. Additional crude product was obtained by extracting the aqueous phase with methylene chloride. The combined crude products (0.65 g) were chromatographed on 25 g of silica gel (methylene chloride/methanol 2%, 5%, 10%). There were obtained 540 mg of (S)-1-(5-propylaminomethyl-1,2,4-oxadiazol-3-yl)-11,12,13,13a-tetrahydro-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepin-9-one, which was dissolved in 5 ml of acetonitrile and thereupon converted with ethereal hydrochloric acid into the hydrochloride. By recrystallization from acetonitrile there were obtained 560 mg (62%) of (S)-1-(5-propylaminomethyl-1,2,4-oxadiazol-3-yl)-11,12,13,13a-tetrahydro-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepin-9-one hydrochloride (1:2) of m.p. 169°-173° (dec.).
Workup
- customThe solution was evaporated
- customthe residue was triturated in 5 ml of water
- filtrationthe crystals were filtered off
- customAdditional crude product was obtained
- extractionby extracting the aqueous phase with methylene chloride
- customwere chromatographed on 25 g of silica gel (methylene chloride/methanol 2%, 5%, 10%)
Sources & evidence
- ORD record
- ord-12d38c75a8404fdea4f0b1a27a071dca
- Source dataset
- uspto-grants-1997_09
- Patent number
- US05665718
Reaction notes
Loading…